When

June 22, 2016 — Wednesday
7:00 am — 9:30 am

Where

Morse Waltham Office, 230 Third Avenue, 4th Floor, Waltham, MA, 02451

The 2nd Session of the Life Sciences Panel Series
will be held on Wednesday, June 22nd!

Every enterprise needs to engineer a strong and flexible foundation to support growth and expansion. In addition to patents and intellectual property, and the right team members, the emerging biotech company should also plan properly from a legal, tax and accounting perspective to build the scaffold to harness the power of possibilities.  Whether it is the entity formation itself, or the optimal vehicles and strategies to compensate directors, employees and advisers with equity, founders need to understand the permutations of the Entity and its Equity. 

Join us at our offices in Waltham on the morning of June 22 to hear experts inform us whether a corporation or a limited liability company is the “Right Stuff” for building an emerging company, and how to maximize the equity compensation of your team with restricted stock, stock options or profits interests. This program is designed for entrepreneurs and scientists, not accountants; for strategic advisers, not technicians.

If you ever have wanted to start a company, here is where you start learning. We hope to see you there on June 22 in Waltham. Breakfast provided, but bring your questions.

Moderator:

John Hession, Partner, Morse

Panel:

Marc Cote, Chief Operating Officer, Accellient

Jeff Solomon, Partner, Katz Nannis + Solomon, @jsolomoncpa

This event is complimentary but seating is limited. 
Networking and refreshments begin at 7:00!